Neuroprotective role of thymoquinone against 1-methyl-4-phenylpyridinium-induced dopaminergic cell death in primary mesencephalic cell culture

References

1. ↵
   1. Harrison IF,
   2. Dexter DT

   (2013) Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease? Pharmacol Ther 140, 34–52.
2. ↵
   1. Glavaski-Joksimovic A,
   2. Bohn MC

   (2013) Mesenchymal stem cells and neuroregeneration in Parkinson's disease. Exp Neurol 247, 25–38.
3. ↵
   1. Utsumi H,
   2. Okuma Y,
   3. Kano O,
   4. Suzuki Y,
   5. Iijima M,
   6. Tomimitsu H,
   7. et al.

   (2013) Evaluation of the efficacy of pramipexole for treating levodopa-induced dyskinesia in patients with Parkinson's disease. Intern Med 52, 325–332.
4. ↵
   1. Chong CM,
   2. Zhou ZY,
   3. Razmovski-Naumovski V,
   4. Cui GZ,
   5. Zhang LQ,
   6. Sa F,
   7. et al.

   (2013) Danshensu protects against 6-hydroxydopamine-induced damage of PC12. cells in vitro and dopaminergic neurons in zebrafish, Neurosci Lett, 543, 121–125.
5. ↵
   1. Qin RA,
   2. Yao XX,
   3. Huang ZY

   (2012) Effects of compound danshen tablets on spatial cognition and expression of brain beta-amyloid precursor protein in a rat model of Alzheimer's disease. J Tradit Chin Med 32, 63–66.
6. ↵
   1. Hosseinzadeh H,
   2. Parvardeh S,
   3. Asl MN,
   4. Sadeghnia HR,
   5. Ziaee T

   (2007) Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus. Phytomedicine 14, 621–627.
7. ↵
   1. Khan A,
   2. Vaibhav K,
   3. Javed H,
   4. Khan MM,
   5. Tabassum R,
   6. Ahmed ME,
   7. et al.

   (2012) Attenuation of Aβ-induced neurotoxicity by thymoquinone via inhibition of mitochondrial dysfunction and oxidative stress. Mol Cell Biochem 369, 55–65.
8. ↵
   1. Kanter M

   (2011) Protective effects of thymoquinone on the neuronal injury in frontal cortex after chronic toluene exposure. J Mol Histol 42, 39–46.
9. ↵
   1. Radad K,
   2. Moldzio R,
   3. Taha M,
   4. Rausch WD

   (2009) Thymoquinone protects dopaminergic neurons against MPP+and rotenone. Phytother Res 23, 696–700.
10. ↵
    1. Radad K,
    2. Moldzio R,
    3. Rausch WD

    (2010) Minocycline protects dopaminergic neurons against long-term rotenone toxicity. Can J Neurol Sci 37, 81–85.
11. ↵
    1. Koh JY,
    2. Choi DW

    (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J Neurosci Methods 20, 83–90.
12. ↵
    1. Gwag BJ,
    2. Lobner D,
    3. Koh JY,
    4. Wie MB,
    5. Choi DW

    (1995) Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience 68, 615–619.
13. ↵
    1. White RJ,
    2. Reynolds IJ

    (1996) Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J Neurosci 16, 5688–5697.
14. ↵
    1. Storch A,
    2. Ludolph AC,
    3. Schwarz J

    (2004) Dopamine transporter: involvement in selective dopaminergic neurotoxicity and degeneration. J Neural Transm 111, 1267–1286.
15. ↵
    1. Kwok KH,
    2. Ho PW,
    3. Chu AC,
    4. Ho JW,
    5. Liu HF,
    6. Yiu DC,
    7. et al.

    (2010) Mitochondrial UCP5 is neuroprotective by preserving mitochondrial membrane potential, ATP levels, and reducing oxidative stress in MPP+and dopamine toxicity. Free Radic Biol Med 49, 1023–1035.
16. ↵
    1. Xu L,
    2. Li W,
    3. Lin D,
    4. Zhang H,
    5. Zou F

    (2013) [Role of calcium dyshomeostasis in 1-methyl-4-phenylpyridinium ion-induced apoptosis of human neuroblastoma SH-SY5Y cells]. Nan Fang Yi Ke Da Xue Xue Bao 33, 479–485.
17. ↵
    1. Nakai M,
    2. Mori A,
    3. Watanabe A,
    4. Mitsumoto Y

    (2003) 1-methyl-4-phenylpyridinium (MPP+) decreases mitochondrial oxidation-reduction (REDOX) activity and membrane potential (Deltapsi(m)) in rat striatum. Exp Neurol 179, 103–110.
18. ↵
    1. Yi F,
    2. He X,
    3. Wang D

    (2013) Lycopene protects against MPP(+)-induced cytotoxicity by maintaining mitochondrial function in SH-SY5Y cells. Neurochem Res 38, 1747–1757.
19. ↵
    1. Tang XQ,
    2. Li YJ,
    3. Zhao J,
    4. Shen XT,
    5. Yang CT,
    6. Fan LL,
    7. et al.

    (2010) Neuroprotective effect of asymmetric dimethylarginine against 1-methyl-4-phenylpyridinium ion-induced damage in PC12 cells. Clin Exp Pharmacol Physiol 37, 530–535.
20. ↵
    1. Kost GC,
    2. Selvaraj S,
    3. Lee YB,
    4. Kim DJ,
    5. Ahn CH,
    6. Singh BB

    (2012) Clavulanic acid inhibits MPP⁺-induced ROS generation and subsequent loss of dopaminergic cells. Brain Res 1469, 129–135.
21. ↵
    1. He C,
    2. Klionsky DJ

    (2010) Analyzing autophagy in zebrafish. Autophagy 6, 642–644.
22. ↵
    1. Ullah I,
    2. Ullah N,
    3. Naseer MI,
    4. Lee HY,
    5. Kim MO

    (2012) Neuroprotection with metformin and thymoquinone against ethanol-induced apoptotic neurodegeneration in prenatal rat cortical neurons. BMC Neurosci 13, 11.
23. ↵
    1. Alhebshi AH,
    2. Gotoh M,
    3. Suzuki I

    (2013) Thymoquinone protects cultured rat primary neurons against amyloid β-induced neurotoxicity. Biochem Biophys Res Commun 433, 362–367.
24. ↵
    1. Zhang X,
    2. Yan H,
    3. Yuan Y,
    4. Gao J,
    5. Shen Z,
    6. Cheng Y,
    7. et al.

    (2013) Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance. Autophagy 9, 1321–1333.